Bosch John Roderick Ten Sells 1,417 Shares of Billiontoone (NASDAQ:BLLN) Stock

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,417 shares of the stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $100.00, for a total transaction of $141,700.00. Following the transaction, the senior vice president owned 26,467 shares in the company, valued at approximately $2,646,700. This represents a 5.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total transaction of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total value of $169,920.00.
• On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The shares were sold at an average price of $101.47, for a total value of $287,363.04.

Billiontoone Trading Down 2.0%

Shares of NASDAQ:BLLN opened at $93.24 on Friday. The company has a market capitalization of $4.40 billion and a PE ratio of 133.20. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. Billiontoone, Inc. has a 12-month low of $61.96 and a 12-month high of $150.44. The business’s fifty day simple moving average is $115.10 and its 200-day simple moving average is $95.27.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The firm had revenue of $109.45 million during the quarter. As a group, equities research analysts predict that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Billiontoone

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Adams Street Partners LLC acquired a new position in shares of Billiontoone in the fourth quarter worth about $140,063,000. Wasatch Advisors LP raised its holdings in Billiontoone by 40.2% in the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after purchasing an additional 148,446 shares during the period. Price T Rowe Associates Inc. MD acquired a new stake in Billiontoone in the fourth quarter valued at approximately $39,717,000. JPMorgan Chase & Co. purchased a new position in shares of Billiontoone during the 4th quarter valued at approximately $32,078,000. Finally, Emerald Advisers LLC lifted its holdings in Billiontoone by 26.8% during the first quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after purchasing an additional 50,613 shares in the last quarter.

Analysts Set New Price Targets

A number of equities research analysts recently commented on BLLN shares. Guggenheim began coverage on shares of Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 target price for the company. JPMorgan Chase & Co. dropped their target price on Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research note on Thursday, August 6th. Wall Street Zen cut Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Finally, BTIG Research dropped their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Six investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $126.71.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.